# CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

> **NCT05942872** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 90 (actual)

## Conditions studied

- Paraneoplastic Syndromes

## Interventions

- **OTHER:** This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.

## Key facts

- **NCT ID:** NCT05942872
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2021-07-15
- **Final completion:** 2021-09-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942872, "CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05942872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*